Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial

INTRODUCTION: Primary membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. The disease may have different long-term outcomes. After 10 years of follow-up, 35%–50% of the untreated patients with persistent nephrotic syndrome may die or progress to end stage renal disease. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Scolari, Francesco, Dallera, Nadia, Gesualdo, Loreto, Santoro, Domenico, Pani, Antonello, Santostefano, Marisa, Feriozzi, Sandro, Mani, Laila-Yasmin, Boscutti, Giuliano, Messa, Piergiorgio, Magistroni, Riccardo, Quaglia, Marco, Ponticelli, Claudio, Ravani, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Medical Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924835/
https://www.ncbi.nlm.nih.gov/pubmed/31806605
http://dx.doi.org/10.1136/bmjopen-2019-029232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924835/
https://www.ncbi.nlm.nih.gov/pubmed/31806605
http://dx.doi.org/10.1136/bmjopen-2019-029232

Ejemplares similares